Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease - Wikidata - awgldk - TriplyDB

Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease

Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease

http://www.wikidata.org/entity/Q33833050

about

Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.MicroRNA expression profile of human advanced coronary atherosclerotic plaques.

P2860

Q49561459-4DE65D75-9945-4E35-A2CA-B03E7CFCD2BA Q55280270-99071127-5AAE-4BCB-8786-2893D30FCD91

P2860

Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease

http://www.wikidata.org/entity/Q33833050

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Circulating mircoRNA-21 as a p ...... ity arterial occlusive disease

@ast

Circulating mircoRNA-21 as a p ...... ity arterial occlusive disease

@en

type

label

Circulating mircoRNA-21 as a p ...... ity arterial occlusive disease

@ast

Circulating mircoRNA-21 as a p ...... ity arterial occlusive disease

@en

prefLabel

Circulating mircoRNA-21 as a p ...... ity arterial occlusive disease

@ast

Circulating mircoRNA-21 as a p ...... ity arterial occlusive disease

@en

P1433

Q33833050-7353A723-902B-4C35-AB8C-BE6880D53B9F

P1476

Q33833050-17254BC4-FACE-4ADA-B019-F06E07FF9E91

P2093

Q33833050-0A4DAD22-01C5-4FF9-99BA-C5585916BB5C

Q33833050-2A128F9C-2D7F-41F1-A30E-8D54C965AD13

Q33833050-2D745079-B87E-47C2-9701-5D35B49DDD35

Q33833050-2DDC5F17-C82D-4BED-B441-E532E1DC26D6

Q33833050-64BA1FE0-4F08-4A7D-B59F-386171971B62

Q33833050-689C2A2B-B0F3-40AE-A683-2C8D47DC8BEB

Q33833050-7BE0E73D-2339-40E2-8F61-4DF25AD1524D

Q33833050-88000DB6-6753-424F-9873-12CAF2F3634D

Q33833050-8FD8FBBE-9E14-4EF9-81C5-66E69E83F6E7

Q33833050-F53F1E79-FD59-45C3-A390-023B605B28A4

P2860

Q33833050-0BA2CB56-3BF2-4B5C-820C-669FBCEE4F96

Q33833050-0FE5C072-D2CB-4890-85CC-0D8D618200C6

Q33833050-0FF01C60-1425-449E-ACC7-64BB326481F5

Q33833050-1741069D-F429-4E27-9F80-9E7C31836DE5

Q33833050-1ED2D4B4-A9B8-43BA-807C-EC43A71EB316

Q33833050-2887239B-B8F1-4BA0-85BB-E61995896072

Q33833050-43F750D6-8F63-4D29-A901-8C057E442781

Q33833050-45121BD0-039B-44F4-8E84-CA81131A91EB

Q33833050-5A46E53C-24FF-4747-844A-2CEABF8671BE

Q33833050-5BAD70EA-5348-4643-B70A-E90E92FE6E99

P31

Q33833050-5010D65E-3AE7-4EAE-8FD9-4B83C67818EB

P356

Q33833050-997A46C3-5013-423D-AD61-5371C547774E

P433

Q33833050-744686C6-D30B-4B0D-AAEB-346FA127094D

P478

Q33833050-0ECDB80D-719C-48D0-A206-80333069F051

P577

Q33833050-88192625-B8A6-40E4-B545-510A48ABBE6C

P698

Q33833050-659CC3C7-7770-4574-BB5C-8DDE87AC5454

P932

Q33833050-FA9D6973-4EF3-4CE6-B009-9D25FF70AA1E

P356

P1433

Bioscience Reports

P1476

Circulating mircoRNA-21 as a p ...... ity arterial occlusive disease

@en

P2093

Bao Jing

http://www.w3.org/2001/XMLSchema#string

Bo Zhang

http://www.w3.org/2001/XMLSchema#string

Chao Yuan

http://www.w3.org/2001/XMLSchema#string

Hai-Yang Wang

http://www.w3.org/2001/XMLSchema#string

Hao-Cheng Li

http://www.w3.org/2001/XMLSchema#string

Qing-Feng Sun

http://www.w3.org/2001/XMLSchema#string

Si-Qi Liu

http://www.w3.org/2001/XMLSchema#string

Tong Jiao

http://www.w3.org/2001/XMLSchema#string

Xin-Yu Liu

http://www.w3.org/2001/XMLSchema#string

Ye Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

MicroRNAs and Endothelial (Dys) Function

Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis

The functions and regulation of the PTEN tumour suppressor

Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease.

Peripheral artery disease: current insight into the disease and its diagnosis and management.

STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.

A selective microRNA-based strategy inhibits restenosis while preserving endothelial function.

microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.

Hunting the needle in the haystack: a guide to obtain biologically meaningful microRNA targets.

P31

scholarly article

P356

10.1042/BSR20160502

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28250135

http://www.w3.org/2001/XMLSchema#string

P932

5484015

http://www.w3.org/2001/XMLSchema#string